Search Results 201-210 of 440 for ❣베스트토토검증【평생베스트.com】베스트토토❣

  1. Heart Disease Clinical Trials - Mayo Clinic Research

    ... best management strategy compared with an initial conservative strategy of optimal medical therapy alone for higher-risk patients with stable ischemic heart ...

  2. A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease - Mayo Clinic

    ... best. Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  3. Heart disease in women: Understand symptoms and risk factors - Mayo Clinic

    Ask your healthcare team what weight is best for you. Manage stress. Stress can cause the arteries to get tight. This can increase the risk of heart disease ...

  4. A Study of Tazemetostat in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Endometrial Cancer - Mayo Clinic

    ... best. Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  5. Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) - Mayo Clinic

    ... best. Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  6. A Clinical Trial to Evaluate the HeartWare Ventricular Assist System (ENDURANCE SUPPLEMENTAL TRIAL) - Mayo Clinic

    ... best. Study IDs. Site IRB. Rochester, Minnesota: 13-006972. NCT ID: NCT01966458. Sponsor Protocol Number: HW004-A Ver. 3.0. About this study. This is a ...

  7. Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant - Mayo Clinic

    ... best. Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  8. A Study of ASP8273 versus Erlotinib or Gefitinib as First-Line Treatment for Patients with Stage IIIB/IV Non-Small Cell Lung Cancer - Mayo Clinic

    ... best. Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  9. Cardiovascular Medicine - Clinical trials - Mayo Clinic

    So the mission and research here is to advance how we can best help the patient, how to make sure the patient comes first in care. So in many ways, it's a ...

  10. Ankle-brachial index - Mayo Clinic

    The ankle-brachial index test is a quick, simple way to check for peripheral artery disease (PAD). The disease happens when narrowed arteries reduce the ...